Ultrasonic blood flow doppler audio with pitch shifting
US-9702969-B2 · Jul 11, 2017 · US
US10687763B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10687763-B2 |
| Application number | US-201414895505-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 13, 2014 |
| Priority date | Jun 24, 2013 |
| Publication date | Jun 23, 2020 |
| Grant date | Jun 23, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A patient monitor device includes one or more sensors which measure physiological parameters of a patient, a controller which controls an audio source to generate an audible tone and adjust the pitch or frequency of the audible tone to indicate the measured physiological parameter according to a mapping scheme, the audio source which generates the audible tone, and an audio output device which outputs the audible tone. The mapping scheme clamping a frequency of the audible tone after reaching a predetermined threshold.
Opening claim text (preview).
The invention claimed is: 1. A patient monitoring device, the device comprising: one or more sensors configured to measure a blood oxygen concentration of a patient; an audio source; a controller configured to control the audio source to generate an audible tone and adjust a frequency of the audible tone to indicate the measured blood oxygen concentration according to a non-linear mapping scheme that corresponds to an octave-based musical scale in which an octave is double a frequency of the tone; an audio output device which outputs the audible tone; wherein the mapping scheme clamps the frequency of the audible tone after reaching a predetermined threshold; and wherein the controller is further configured to, for each one percent change in the blood oxygen concentration, step the frequency of the audible tone in accordance with the non-linear mapping scheme by one half tone or one full tone of the octave-based musical scale. 2. The device according to claim 1 , wherein the audible tone includes an audible tone for each characteristic point in a cardiac cycle. 3. The device according to claim 1 , wherein the predetermined threshold is two octaves below a peak frequency. 4. The device according to claim 1 , wherein the controller modifies the audible tone after reaching the predetermined threshold. 5. The device according to claim 1 , wherein the controller transposes the audible tone based on a type of the audio output device. 6. The device according to claim 1 , wherein the controller is further configured to: transpose the audible tone based on a type of the audio output device. 7. A system comprising: a first patient monitoring device comprising a patient monitoring device according to claim 1 ; and a second patient monitoring device comprising a patient monitoring device according to claim 1 ; wherein the controller of the first patient monitoring device is configured to transpose the audible tone of the first patent monitoring device to operate in a different octave than the audible tone of the second patient monitoring device. 8. A method for tone modulation with an audible lower clamp value, the method comprising: measuring a blood oxygen concentration of a patient with one or more sensors; generating an audible tone and adjusting a frequency of the audible tone to indicate the measured blood oxygen concentration according to a non-linear mapping scheme that corresponds to an octave-based musical scale in which an octave is double a frequency of the tone, wherein the non-linear mapping scheme clamps the frequency of the audible tone after reaching a predetermined threshold; and stepping the frequency of the audible tone in full-tone or half-tone increments based on the blood oxygen concentration; wherein for each one percent change in the blood oxygen concentration the frequency is changed by one half-tone or one full-tone of the octave-based musical scale. 9. The method according to claim 8 , wherein the audible tone includes an audible tone for each characteristic point in a cardiac cycle. 10. The method according to claim 8 , wherein the predetermined threshold is two octaves below a peak frequency. 11. The method according to claim 8 , further including: modifying the audible tone after reaching the predetermined threshold. 12. The method according to claim 8 , further including: transposing the audible tone based on a type of audio output device.
for measuring blood gases (A61B5/14551 takes precedence) · CPC title
Sound rendering of measured values, e.g. by pitch or volume variation (A61B5/741 takes precedence) · CPC title
Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value {; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue} (non-radiation detecting or locating of foreign bodies in blood A61B5/06) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.